933 reports of this reaction
1.8% of all MYCOPHENOLIC ACID reports
#9 most reported adverse reaction
FATIGUE is the #9 most commonly reported adverse reaction for MYCOPHENOLIC ACID, manufactured by Novartis Pharmaceuticals Corporation. There are 933 FDA adverse event reports linking MYCOPHENOLIC ACID to FATIGUE. This represents approximately 1.8% of all 51,116 adverse event reports for this drug.
MYCOPHENOLIC ACID has an overall safety score of 88 out of 100. Patients taking MYCOPHENOLIC ACID who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is a less commonly reported adverse event for MYCOPHENOLIC ACID, but still significant enough to appear in the safety profile.
In addition to fatigue, the following adverse reactions have been reported for MYCOPHENOLIC ACID:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 933 FDA reports for MYCOPHENOLIC ACID. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 1.8% of all adverse event reports for MYCOPHENOLIC ACID, making it a notable side effect.
If you experience fatigue while taking MYCOPHENOLIC ACID, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.